A strategic view of randomized trial design in low-incidence paediatric cancer

Statistics in Medicine

Volumn 18, Issue 10, 1999, Pages 1183-1197

  Sposto, Richard ^a,b   Stram, Daniel O ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEASIBILITY STUDY; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SAMPLE; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CLINICAL TRIALS, PHASE III; COMPUTER SIMULATION; DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; MODELS, STATISTICAL; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0033617681     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19990530)18:10<1183::AID-SIM122>3.0.CO;2-P     Document Type: Article

References (22)

1. Meinert, C. L. Clinical Trial: Design, Conduct and Analysis, Oxford University Press, New York, 1986.
2. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J. and Smith, P. G. 'Design and analysis of randomized clinical trials requiring prolonged observation of each patient', British Journal of Cancer, 34, 585-612 (1976).
3. Simon, R. 'Size of phase III cancer clinical trials', Cancer Treatment Reports' 69, 1087-1093 (1985).
4. Moher, D., Dulberg, C. S. and Wells, G. A. 'Statistical power, sample size, and their reporting in randomized controlled trials', Journal of the American Medical Association, 272, 122-124 (1994).
5. Ross, J. A., Severson, R. K., Pollock, B. H. and Robison, L. L. 'Childhood cancer in the United States - a geographical analysis of cases from the Paediatric Cooperative Clinical Trials Groups', Cancer, 77, 201-207 (1996).
6. Bechhofer, R. E., Santner, T. J. and Goldsman, D. M. Design and Analysis of Experiments for Statistical Selection, Screening, and Multiple Comparisons, Wiley, New York, 1995.
7. Simes, R. J. 'Application of statistical decision theory to treatment choices: implications for the design and analysis of clinical trials', Statistics in Medicine, 5, 411-450 (1986).
8. Strauss, N. and Simon, R. 'Investigating a sequence of randomized phase II trials to discover promising treatments', Statistics in Medicine, 14, 1479-1489 (1995).
9. Thall, P. F., Simon, R. and Ellenberg, S. S. 'A two-stage design for choosing among several experimental treatments and a control in clinical trials', Biometrics, 45, 537-547 (1989).
10. Whitehead, J. 'Designing phase II studies in the context of a programme of clinical research', Biometrics, 41, 373-383 (1985).
11. Patte, C., Philip, T., Rodary, C., Zucker, J. M., Behrendt, H., Gentet, J. C., Lamagnere, J. P., Otten, J., Dufillot, D., Pein, F., Caillou, B. and Lemerle, J. 'High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children', Journal of Clinical Oncology, 9, 123-132 (1991).
12. Gaynon, P. S., Steinherz, P. G., Bleyer, W. A., Ablin, A. R., Albo, V. C., Finklestein, J. Z., Grossman, N. J., Littman, P. S., Novak, L. T., Pyesmany, A. F., Reaman, G. H., Sather, H. N. and Hammond, G. D. 'Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group', Lancet, 2, 921-924 (1988).
13. Sposto, R. and Sather, H. N. 'Determining the duration of comparative clinical trials while allowing for cure', Journal of Chronic Diseases, 38, 683-690 (1985).
14. Kalbfleisch, J. D. and Prentice, R. L. The Statistical Analysis of Failure Time Data, Wiley, New York, 1980.
15. Gray, R. J. and Tsiatis, A. A. 'A linear rank test for use when the main interest is in differences in cure rates', Biometrics, 45, 899-904 (1989).
16. Whitehead, J. 'The case for frequentism in clinical trial', Statistics in Medicine, 12, 15-16 (1993).
17. Berry, D. A. 'A case for Bayesianism in clinical trials', Statistics in Medicine, 12, 1377-1393 (1993).
18. Brophy, J. M. and Joseph, L. 'Placing trials in context using Bayesian analysis: GUSTO revisited by Reverend Bayes', Journal of the American Medical Association, 273, 871-875 (1995).
19. Sposto, R. and Stram, D. 'Clinical research strategy and the design of pediatric cancer trials', Children's Cancer Group Biostatistics Technical Report, 1996.
20. Novakovic, B. 'U.S. childhood cancer survival, 1973-1987', Medical and Pediatric Oncology, 23, 480-496 (1994).
21. Thall, P. F., Simon, R. M. and Estey, E. H. 'New statistical strategy for monitoring safety and efficacy in single-arm clinical trials', Journal of Clinical Oncology, 14, 296-303 (1996).
22. Conaway, M. R. and Petroni, G. R. 'Designs for phase II trials allowing for a trade-off between response and toxicity', Biometrics, 52, 1375-1386 (1996).